Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
Hepatology (Baltimore, Md.)|February 15, 2019
Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L-PLUS 2)Markus Peck-Radosavljevic, Krzysztof Simon, Angelo Iacobellis, et al.The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|October 5, 2021
Recommendations for Hepatitis B Immunoglobulin and Antiviral Prophylaxis Against Hepatitis B Recurrence After Liver TransplantationMesut Akarsu, Soner Onem, Ilker Turan, et al.The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|December 8, 2021
Characteristics of Newly Diagnosed Hepatocellular Carcinoma Patients Across Turkey: Prospective Multicenter Observational 3K Registry StudyUlus Salih Akarca, Belkis Unsal, Orhan Sezgin, et al.Hepatology (Baltimore, Md.)|October 29, 2014
Adding pegylated interferon to entecavir for hepatitis B e antigen-positive chronic hepatitis B: A multicenter randomized trial (ARES study)Willem Pieter Brouwer, Qing Xie, Milan J Sonneveld, et al.Journal of Viral Hepatitis|February 12, 2019
Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real-world chronic hepatitis C patients cohortRamazan Idilman, Mehmet Demir, Murat Aladag, et al.Journal of Viral Hepatitis|September 7, 2018
Long-term follow-up of patients treated with entecavir and peginterferon add-on therapy for HBeAg-positive chronic hepatitis B infection: ARES long-term follow-upMargo J H van Campenhout, Willem Pieter Brouwer, Qing Xie, et al.Hepatology Forum|January 29, 2024
Changing trends in the etiology of liver transplantation in Turkiye: A multicenter studyMesut Akarsu, Suleyman Dolu, Murat Harputluoglu, et al.Hepatology Forum|January 27, 2026
Efficacy and tolerability of tenofovir alafenamide fumarate prophylaxis in HBV-infected individuals receiving chemo/immunosuppressive therapyFeyza Dilber, Serdar Durak, Yasemin Unsal, et al.Hepatology Forum|October 12, 2023
The efficacy and tolerability of glecaprevir/pibrentasvir treatment in a real-world chronic hepatitis C patients cohortSerkan Yaras, Mehmet Demir, Sezgin Barutcu, et al.Hepatology Forum|September 30, 2022
Characteristics of patients with hepatocellular carcinoma: A multicenter studyFatih Guzelbulut, Umit Karaogullarindan, Hikmet Akkiz, et al.Pageof 6